Role of Dopaminergic Gene Polymorphisms (DBH 19bp Indel and DRD2 Nco I) in Genetic Susceptibility to Migraine in North Indian Population

Pain Medicine

Volumn 12, Issue 7, 2011, Pages 1109-1111

  Ghosh, Jayashri ^a   Pradhan, Sunil ^a   Mittal, Balraj ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Dopamine Receptor D2 Gene; Dopamine Hydroxylase Gene; Genetic Susceptibility; Migraine

Indexed keywords

ALLELE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; FEMALE; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; INDEL MUTATION; INDIA; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEX DIFFERENCE;

EID: 79960349278     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2011.01153.x     Document Type: Article

References (13)

1. Blau JN. Migraine: Theories of pathogenesis. Lancet 1992;339:1202-6.
2. Weinshilboum R, Axelrod J. Serum dopamine-beta-hydroxylase activity. Circ Res 1971;28:307-15.
3. Kelly AM, Ardagh M, Curry C, D'Antonio J, Zebic S. Intravenous chloropromazine versus intramuscular sumatriptan for acute migraine. J Accid Emerg Med 1997;14:209-11.
4. Cubells JF, Kranzler HR, McCance-Katz E, etal. A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity, also associates with cocaine- induced paranoia. Mol Psychiatry 2000;5:56-63.
5. Fernandez F, Lea RA, Colson NJ, etal. Association between a 19bp deletion polymorphism at the dopamine beta-hydroxylase (DBH) locus and migraine with aura. J Neurol Sci 2006;251:118-23.
6. Todt U, Netzer C, Toliat M, etal. New genetic evidence for involvement of the dopamine system in migraine with aura. Hum Genet 2009;125(3):265-79.
7. Duan J, Wainwright MS, Comeron JM, etal. Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet 2003;12:205-16.
8. Peroutka SJ, Price SC, Wilhoit TL, Jones KW. Comorbid migraine with aura, anxiety, and depression is associated with dopamine D2 receptor (DRD2) Nco I alleles. Mol Med 1998;4:14-21.
9. Dichgans M, Forderreuther S, Deiterich M, Pfaffenrath V, Gasser T. The D2 receptor Nco I allele: Absence of allelic association with migraine with aura. Neurology 1998;51:928.
10. Headache Classification Subcommittee of the International Headache Society (HCCIHS). The international classification of headache disorders, 2nd edn. Cephalalgia 2004;24(suppl):1-160.
11. Joshi G, Pradhan S, Mittal B. Role of estrogen receptor (ESRI PvuII and ESRI 325 C>G) and progesterone receptor (PROGINS) polymorphisms in genetic susceptibility to migraine in a North Indian population. Cephalalgia 2009;30(3):311-20.
12. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16(3):1215.
13. Martinez F, Castillo J, Pardo J, Lema M, Noya M. Catecholamine levels in plasma and CSF in migraine. J Neurol Neurosurg Psychiatry 1993;56:1119-21.